Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
Fig. 3A
Delhermite J et al. (2022) |
Xla Wt + fbl MO
NF15-18 (in situ hybridization) |
|||||
Fig. 3A
Delhermite J et al. (2022) |
Xla Wt + fbl MO
NF32 (in situ hybridization) |
|||||
Fig. 2 i
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|
||||
Fig. 2 l
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF17 (in situ hybridization) |
|
||||
Fig.2.c
Vega-López GA et al. (2015) |
Xla Wt + smad4.2
NF16 (in situ hybridization) |
|
||||
Fig.2.f
Vega-López GA et al. (2015) |
Xla Wt + smad4.2
NF16 (in situ hybridization) |
|
||||
Fig.2.j
Vega-López GA et al. (2015) |
Xla Wt + canotch1-GR
NF16 (in situ hybridization) |
|
||||
Fig.2.n
Vega-López GA et al. (2015) |
Xla Wt + canotch1-GR
NF16 (in situ hybridization) |
|
||||
Fig.2.h
Vega-López GA et al. (2015) |
Xla Wt + carbpj-notch1del-GR
NF16 (in situ hybridization) |
|
||||
Fig.2.i
Vega-López GA et al. (2015) |
Xla Wt + carbpj-notch1del-GR
NF16 (in situ hybridization) |
|